Abstract
Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide. Currently, surgery is the treatment of choice for GC. However, the associated expenses and post-surgical pain impose a huge burden on these patients. Furthermore, disease recurrence is also very common in GC patients, thus necessitating the discovery and development of other potential treatment options. A growing body of knowledge about ferroptosis in different cancer types provides a new perspective in cancer therapeutics. Ferroptosis is an iron-dependent form of cell death. It is characterized by intracellular lipid peroxide accumulation and redox imbalance. In this review, we summarized the current findings of ferroptosis regulation in GC. We also tackled on the action of different potential drugs and genes in inducing ferroptosis for treating GC and solving drug resistance. Furthermore, we also explored the relationship between ferroptosis and the tumor microenvironment in GC. Finally, we discussed areas for future studies on the role of ferroptosis in GC to accelerate the clinical utility of ferroptosis induction as a treatment strategy for GC.
Introduction
Gastric cancer (GC) is the fifth most common cancer and the third leading cause of cancer-related deaths worldwide (Smyth et al., 2020). Some of the risk factors for this disease include Helicobacter pylori infection, age, high salt intake, and unhealthy diet (Chen et al., 2021a). GC is commonly treated with surgery (Mihmanli et al., 2016). However, the associated expenses and post-surgical pain impose a huge burden on GC patients. Several studies which focused on identifying molecular signatures and genetic alterations in GC in order to improve treatment selection and aid drug development have already been conducted (Lordick et al., 2017). However, the underlying mechanisms in disease progression are still unclear. Thus, an in-depth understanding of the GC pathobiology will not only facilitate the identification of new drug targets but also provide help in the development of new clinical treatment strategies.
Ferroptosis is a relatively new form of programmed cell death, which was first described in 2012 (Dixon et al., 2012). Several studies have implicated the contribution of ferroptosis in the progression of multiple diseases (Galluzzi et al., 2018; Stockwell et al., 2020), including GC (Jiang et al., 2021a; Liu G. et al., 2021). In this review, we summarized the relationship between ferroptosis and gastric cancer. Furthermore, we suggested that effective regulation of iron metabolism may provide a novel strategy for treating gastric cancer.
Iron Metabolism in Gastric Cancer
Iron is an indispensable molecule in almost all living organisms. Iron-containing enzymes are involved in many physiological activities (Dixon and Stockwell, 2014), such as cellular metabolism, oxygen transport, DNA synthesis, energy production, and cellular respiration. Aside from its roles in various life processes, the catalytic form of iron can also catalyze the formation of reactive oxygen species (ROS) in oxygen-rich environments. Interestingly, iron and ROS can initiate and mediate cell death in several organisms and disease states (Fischbacher et al., 2017). In addition, ROS can also affect several processes, such as cell survival, proliferation, and differentiation through multiple signaling pathways (Lambeth and Neish, 2014). Although low cellular ROS levels are beneficial to some extent, it has also been found to result in base modification and DNA strand breaks (Inoue and Kawanishi, 1987; Dizdaroglu et al., 1991). These findings hint at the potential contribution of free radical-induced DNA damage in the etiology of numerous diseases, including cancer (Dizdaroglu and Jaruga, 2012). Consistent with this idea, extensive studies have shown that poor regulation of iron metabolism is associated with many diseases, including atherosclerosis, neurodegenerative disorders, and cancer (Lambeth and Neish, 2014; Zhou et al., 2018; Vinchi et al., 2019).
Iron levels and stomach health are closely interrelated. For example, several iron-related conditions, such as unexplained iron deficiency, idiopathic thrombocytopenic purpura, and anemia, were found to be associated with H. pylori infection (Hagymási and Tulassay, 2014; Durazzo et al., 2021). Iron homeostasis has also been implicated in cancer development. In one study, iron oxidation has been shown to contribute to tumor formation and subsequent cancer development (Torti and Torti, 2013). On the other hand, several studies reported that iron deficiency may enhance the risk of developing cancer (Janssen et al., 2020). Anemia, low serum ferritin levels, and autoimmune gastritis–related iron malabsorption were identified as risk factors associated with gastrointestinal tumors and GC (Nomura et al., 1992; Cover et al., 2013; Kamada et al., 2021). Consistent with these studies, in vivo data from rodent models show that iron deficiency may contribute to early progression of gastrointestinal tumors (Prá et al., 2009). Taken together, these studies highlight the significant role of iron in the development of various gastrointestinal malignancies, and the potential value of iron regulation as a treatment strategy (Palzer et al., 2021).
Mechanism of Ferroptosis
Ferroptosis is a unique form of cell death (Kerr et al., 1972; Jacobson and Raff, 1995; Christofferson and Yuan, 2010; Shimada et al., 2016). Some protein modulators, such as p53, can exert their physiologic functions either through apoptosis or ferroptosis (Jiang et al., 2015). Similarly, several small molecules can initiate cell death via specific molecular events related to either ferroptosis, apoptosis, or necrosis (Kerr et al., 1972; Schweichel and Merker, 1973; Yang and Stockwell, 2008; Dixon et al., 2012; Shimada et al., 2016). The activation of distinct pathways suggests that the molecular mechanism involved in ferroptosis differs from those of apoptosis and necrosis (Dixon et al., 2012; Dong et al., 2015; Shimada et al., 2016; Torii et al., 2016).
Iron accumulation is the first step in ferroptosis (Galluzzi et al., 2015). Free ferric iron (Fe3+) in the blood conjugates with transferrin proteins. The iron-bound transferrin molecules are then captured by the transferrin receptors present on the cell membrane and enter the cell through endocytosis (Gao et al., 2019). Reducing proteins, such as six transmembrane proteins of prostate 3 (STEAP3), reduces Fe3+ to its highly reactive ferrous ion (Fe2+) form. Upon conversion, Fe2+ is transported from the endosomes to the cytoplasm and is included to the labile iron pool. To protect the cells and tissues from iron-mediated damage, excess Fe2+ in the iron pool is stored in ferritin, while the remaining Fe2+ can be pumped out of the cell through ferroportin molecules on the cell membrane (Yang et al., 2016; Hassannia et al., 2019). Under normal conditions, intracellular iron concentrations remain stable (Yamaguchi et al., 2021). However, in cases of iron overload, excessive Fe2+ is produced within the cell. The accumulation of intracellular Fe2+ further leads to the production of Fe3+ and ROS through the Fenton chemical reaction (Talvenmäki et al., 2019). In addition, excess Fe3+ can also be reduced to Fe2+ through the Haber–Weiss reaction (Kehrer, 2000). Furthermore, under stress conditions, ferritin can self-degrade into Fe2+ through iron autophagy (Talvenmäki et al., 2019). Collectively, these processes can lead to ferroptosis, which in turn induces the formation of more ROS. Excessive ROS can damage biofilms, proteins, and nucleic acids eventually leading to cell death (Kehrer, 2000).
The high intracellular ROS and free radical levels are usually controlled by cells through the actions of antioxidants such as glutathione (GSH) and glutathione peroxidase 4 (GPX4) (Aldini et al., 2018). However, in some cases, glutathione and GPX4 are used up by the cells in other processes, such as in regulating amino acid metabolism. The intracellular levels of glutathione are also affected by amino acid availability. Increased glutamine decomposition may affect the synthesis of glutathione and cause a cell death event similar to a GSH consumption–induced ferroptosis (Linkermann et al., 2014a; Yang et al., 2014). Furthermore, since GPX4 converts the potentially toxic lipid hydroperoxides (L-OOH) to non-toxic lipid alcohols (L-OH) (Ursini et al., 1982), the inactivation of GPX4 can ultimately cause cell death (Linkermann et al., 2014b) (Figure 1).
FIGURE 1
Ferroptosis in Gastric Cancer
Proliferation, Invasion, and Metastasis of Gastric Cancer
The proliferation, invasion, and metastasis of tumor cells are crucial events in the occurrence and development of malignant tumors. These cell activities lead to varying degrees of clinical responses (Machlowska et al., 2018). Like in other cancer types, GC develops from preneoplastic and early neoplastic precursor lesions (Song et al., 2015). These lesions may develop into tumors when the rate of cell proliferation is faster than cell death (Ginsberg et al., 1996; Li et al., 2018). Early stages of GC are characterized by good prognosis with 5-year survival rates reaching >90%; however, most patients are already in the advanced stages of the disease upon initial diagnosis (Tan, 2019). To date, curative surgical resection procedure is the only available treatment for GC (Santoro et al., 2014). Unfortunately, the metastasis of malignant tumors often causes treatment failure (Coburn et al., 2018; Hatta et al., 2020). Tumor invasion and metastasis refer to cellular events when malignant tumor cells continue to grow from the primary site into other sites through lymphatic, vascular, or the body cavity routes. The origin of tumor cells, genetic variations, circulatory mode, and the physiological structure of the metastatic organ determine the specific sites for distant metastasis (Jin et al., 2014).
Several studies try to identify other potential candidates for GC treatment (Table 1). One of these substances, Tanshinone IIA, can inhibit tumor proliferation and metastasis by increasing the level of lipid peroxides and decreasing that of glutathione in the GC cells (Ni et al., 2021a). Another extract, Actinidia chinensis (Planch) exerts anti-proliferation and anti-migration effects on GC cells. Additionally, it can significantly downregulate the expression of GPX4 in a dose-dependent manner (Gao et al., 2020). On the other hand, physcion 8-O-β-glucopyranoside displays antitumor effects in several cancer types, and it induces ferroptosis by regulating the miR-103a-3p/GLS2 axis in GC (Niu et al., 2019).
TABLE 1
| Substances and Genes | Target/Function | Mechanism |
|---|---|---|
| Actinidia chinensis Planch (Gao et al., 2020) | GPx4, SLC7A11 | Induces ROS accumulation |
| Tanshinone IIA (Guan et al., 2020) | Ptgs2, Chac1, p53, xCT | Tanshinone IIA upregulates p53 expression and downregulates xCT expression; Tan IIA decreases intracellular glutathione and cysteine levels and increases the levels of intracellular ROS. |
| Tanshinone IIA (Ni et al., 2021a) | SLC7A11 | Induces ROS accumulation |
| Physcion 8-O-β-glucopyranoside (Niu et al., 2019) | GLS2 | Induces ROS accumulation |
| Erastin (Sun et al., 2020) | Mitochondrial dysfunction | Induces ROS accumulation |
| Erastin (Chen L. et al., 2020; Mao et al., 2021) | SLC7A11 | Induces ROS accumulation |
| Cysteine Dioxygenase 1 | GPX4, maintains stability of mitochondrial morphology | Mediates erastin (Hao et al., 2017); induces ROS accumulation |
| Exosomes miR-522 (Zhang et al., 2020) | ALOX15 | Leads to ALOX15 suppression, decreased lipid-ROS accumulation in cancer cells, and ultimately results in decreased chemosensitivity |
| SIRT6 (Cai et al., 2021) | GPX4 | Inhibits GPX4 activity, induces ROS accumulation |
| CPEB1 (Wang J. et al., 2021) | Gpx4 | Induces ROS accumulation |
| MiR-375 (Ni et al., 2021b) | SLC7A11 | Induces ROS accumulation |
Candidate substances and genes for inducing ferroptosis in gastric cancer.
Consistent with the studies on the relationship of iron and GC, ferroptosis has also been found to be closely related to the proliferation, invasion, and metastasis in GC (Chen et al., 2021a; Huang et al., 2021). However, the predictive role of ferroptosis in GC remains elusive (Shao et al., 2021). Thus, understanding the processes underlying ferroptosis is promising for the development of cancer treatment strategies.
Tumor Microenvironment in Gastric Cancer
A tumor is closely connected with where it arises and develops in the organism (Chen et al., 2015). Tumor cells in tumor microenvironment (TME) play an active role in the disease progression (Bubnovskaya and Osinsky, 2020; Jiang et al., 2020). The TME favors the growth and expansion of cancer cells (Oya et al., 2020; Rojas et al., 2020). Interestingly, tumor cells and their surrounding microenvironment can be shaped by varying degrees of ferroptosis activation (Zavros, 2017; Xiao et al., 2021). It has been found that ferroptosis serves as an important factor in the formation of the TME in GC (Jiang et al., 2021b; Wang F. et al., 2021; Chen et al., 2021b). In addition, numerous studies have demonstrated that dying cells, including ferroptotic cancer cells, communicate with the immune cells in the TME via a series of signals (Friedmann Angeli et al., 2019). These signals produced during cell death allow the recruitment and activation of immune cells, such as macrophages, regulatory T cell, and neutrophils (Matsushita et al., 2015; Klöditz and Fadeel, 2019; Li et al., 2019), which regulate the growth and expansion of other cancer cells.
Tumor-associated macrophages are emerging as key players in the development of GC (Gambardella et al., 2020). Aside from its role in phagocytosis of foreign antigens, another physiological function of macrophages is to maintain the iron balance in human tissues. Iron homeostasis should be tightly maintained since excess labile iron is toxic (Henle and Linn, 1997; Muckenthaler et al., 2017). Surprisingly, malignant cells can evade the deleterious effect of excessive iron and require high amounts of these reactive ions for their proliferation (Pfeifhofer-Obermair et al., 2018). Depending on the circumstances, increased iron traffic by tumor-associated macrophages either promotes tumor progression or tumor protraction (Soares and Hamza, 2016). Therefore, the detection of macrophages and iron levels in the TME may provide a basis for predicting tumor progression (Liu S. J. et al., 2021; Xiang et al., 2021) (Figure 2). To better understand the functional role of ferroptosis and immune cells in TME, a comprehensive investigation of ferroptosis-related signals and the immune responses they trigger is warranted.
FIGURE 2
Despite of reduction in the incidence of GC and the development of novel therapeutic strategies, the prognosis of GC remains poor (Lazăr et al., 2018). Biomarkers for the characterization of the tumor immune microenvironment may add to the predictive value of the current staging system (Jiang et al., 2019). In recent decades, large-scale clinical trans-omics studies allowed the identification of some crucial ferroptosis-related genes as reliable biomarkers to describe the tumor immune microenvironment landscape and predict response to antitumor therapy (Liu S. J. et al., 2021; Shao et al., 2021).
Drug Resistance in Gastric Cancer
Resistance to cisplatin and paclitaxel has become increasingly severe in GC patients (Shao et al., 2019; Zhai et al., 2019). This proves to be a major hurdle in clinical oncology and leads to poor prognosis (Chen Z. et al., 2020; Wei et al., 2020). Resistance to chemotherapy is usually related to mutations in genes regulating cell apoptosis and increased levels of glutathione (Silva et al., 2019). Interestingly, ferroptosis inducers may help in overcoming drug resistance and warrants further investigation (Shin et al., 2018).
Owing to genetic alterations and abnormal growth, cancer cells have higher oxidative tolerance from ROS than non-malignant cells. This ability is attributed to the maintenance of high levels of the antioxidant GSH, which is essential for cell survival and proliferation (Cramer et al., 2017). Studies show that blocking CAF-exosomes–mediated lipid-ROS inhibition leads to increased levels of ferroptosis in cancer cells, which in turn enhances cell sensitivity towards chemotherapy (Zhang et al., 2020). Another potential target for GC therapy is through the blockage of the ROS-activated GCN2-eIF2α-ATF4-xCT pathway, a signaling cascade leading to mitochondrial dysfunction-enhanced cisplatin resistance (Wang et al., 2016). In addition, regulating ROS levels may serve as another novel therapeutic strategy, since ROS can disturb the cellular oxidative environment and induce cell death (Dharmaraja, 2017). In line with this, studies have shown that the antioxidant enzyme, peroxiredoxin 2, significantly sensitizes the AGS and SNU-1 cells towards cisplatin treatment by regulating the level of ROS (Wang et al., 2020). As chronic and exorbitant ROS levels instigate drug resistance (Liao et al., 2019; Xu et al., 2020; Zhu et al., 2020), regulating ferroptosis may be a useful strategy for targeting the drug-resistant tumor cells (Yang et al., 2017; Huang et al., 2019; Choi et al., 2020; Zhang et al., 2021). A possible relevant mechanism is presented in Figure 3.
FIGURE 3
Conclusion
Gastric adenocarcinoma is a common disease worldwide. Currently, surgery is the only considered effective treatment strategy. However, disease recurrence is very common even after complete resection (Johnston and Beckman, 2019). Interestingly, ferroptosis has been found to have a very vital role in several cancer types, especially in GC (Lee et al., 2020). As a relatively new discovered mode of cell death, the field of ferroptosis is a research hotspot. Although numerous studies have examined the biological mechanisms underlying ferroptosis, its relationship to tumor progression remains to be poorly understood.
In this review, we have highlighted the importance of iron metabolism and ferroptosis in GC. Iron is an important nutrient in humans (Tan et al., 1997; Goddard et al., 2011). However, iron oxidation also contributes to tumor formation and development of cancer (Doll et al., 2019). In addition, iron in macrophages of the tumor microenvironment is an important index for predicting and detecting GC as well as for evaluating the clinical utility of the related gene signature. Meanwhile, ferroptosis is an iron-dependent form of cell death, which is often characterized by the accumulation of lipid peroxidation products in a cellular-iron–dependent manner (Stockwell et al., 2017; Tang et al., 2021). It functions through two main pathways: iron metabolism and Xc system–induced ROS production (Zheng and Conrad, 2020). Different inducers can affect different steps in ferroptosis to regulate GC proliferation, invasion, and metastasis. Furthermore, the development of drug resistance in GC cells poses a major hurdle. As chronic and exorbitant ROS levels instigate drug resistance, ROS homeostasis may provide a useful treatment strategy for targeting the drug-resistant tumor cells.
Taken together, this review tries to elucidate the relationship between ferroptosis and GC, based on available research findings. We summarized the known ferroptosis processes mediated by gastric cancer-related biomolecules and discussed the actions of some drugs in the different pathways involved in ferroptosis. Lastly, this may serve as a reference for future studies on the mechanism of ferroptosis and the treatment of GC.
Statements
Author contributions
All authors listed have made a substantial, direct, and intellectual contribution to the work, and approved it for publication.
Funding
This project was supported in part by the National Natural Science Foundation of China (82074312).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Abbreviations
CAFs, cancer-associated fibroblasts; DMT1, divalent metal transporter 1; GC, gastric cancer; Gpx4, glutathione peroxidase 4; ncRNAs, noncoding RNAs; PUFA, polyunsaturated fatty acid; ROS, reactive oxygen species; STEAP3, six transmembrane protein of prostate 3.
References
1
AldiniG.AltomareA.BaronG.VistoliG.CariniM.BorsaniL.et al (2018). N-acetylcysteine as an Antioxidant and Disulphide Breaking Agent: the Reasons Why. Free Radic. Res.52 (7), 751–762. 10.1080/10715762.2018.1468564
2
BubnovskayaL.OsinskyD. (2020). Tumor Microenvironment and Metabolic Factors: Contribution to Gastric Cancer. Exp. Oncol.42 (1), 2–10. 10.32471/exp-oncology.2312-8852.vol-42-no-1.14056
3
CaiS.FuS.ZhangW.YuanX.ChengY.FangJ. (2021). SIRT6 Silencing Overcomes Resistance to Sorafenib by Promoting Ferroptosis in Gastric Cancer. Biochem. Biophysical Res. Commun.577, 158–164. 10.1016/j.bbrc.2021.08.080
4
ChenD.ChenH.ChiL.FuM.WangG.WuZ.et al (2021). Association of Tumor-Associated Collagen Signature with Prognosis and Adjuvant Chemotherapy Benefits in Patients with Gastric Cancer. JAMA Netw. Open4 (11), e2136388. 10.1001/jamanetworkopen.2021.36388
5
ChenF.ZhuangX.LinL.YuP.WangY.ShiY.et al (2015). New Horizons in Tumor Microenvironment Biology: Challenges and Opportunities. BMC Med.13, 45. 10.1186/s12916-015-0278-7
6
ChenL.QiaoL.BianY.SunX. (2020). GDF15 Knockdown Promotes Erastin-Induced Ferroptosis by Decreasing SLC7A11 Expression. Biochem. Biophysical Res. Commun.526 (2), 293–299. 10.1016/j.bbrc.2020.03.079
7
ChenX.ZehH. J.KangR.KroemerG.TangD. (2021a). Cell Death in Pancreatic Cancer: from Pathogenesis to Therapy. Nat. Rev. Gastroenterol. Hepatol.18 (11), 804–823. 10.1038/s41575-021-00486-6
8
ChenX.ZhuZ.LiX.YaoX.LuoL. (2021b). The Ferroptosis-Related Noncoding RNA Signature as a Novel Prognostic Biomarker in the Tumor Microenvironment, Immunotherapy, and Drug Screening of Gastric Adenocarcinoma. Front. Oncol.11, 778557. 10.3389/fonc.2021.778557
9
ChenZ.LiY.TanB.ZhaoQ.FanL.LiF.et al (2020). Progress and Current Status of Molecule-Targeted Therapy and Drug Resistance in Gastric Cancer. Drugs Today56 (7), 469–482. 10.1358/dot.2020.56.7.3112071
10
ChoiH.-J.JheY.-L.KimJ.LimJ. Y.LeeJ. E.ShinM.-K.et al (2020). FoxM1-dependent and Fatty Acid Oxidation-Mediated ROS Modulation Is a Cell-Intrinsic Drug Resistance Mechanism in Cancer Stem-like Cells. Redox Biol.36, 101589. 10.1016/j.redox.2020.101589
11
ChristoffersonD. E.YuanJ. (2010). Necroptosis as an Alternative Form of Programmed Cell Death. Curr. Opin. Cel Biol.22 (2), 263–268. 10.1016/j.ceb.2009.12.003
12
CoburnN.CosbyR.KleinL.KnightG.MalthanerR.MamazzaJ.et al (2018). Staging and Surgical Approaches in Gastric Cancer: A Systematic Review. Cancer Treat. Rev.63, 104–115. 10.1016/j.ctrv.2017.12.006
13
CoverT. L.Peek, JrR. M.Jr (2013). Diet, Microbial Virulence, andHelicobacter Pylori-Induced Gastric Cancer. Gut Microbes4 (6), 482–493. 10.4161/gmic.26262
14
CramerS. L.SahaA.LiuJ.TadiS.TizianiS.YanW.et al (2017). Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth. Nat. Med.23 (1), 120–127. 10.1038/nm.4232
15
DharmarajaA. T. (2017). Role of Reactive Oxygen Species (ROS) in Therapeutics and Drug Resistance in Cancer and Bacteria. J. Med. Chem.60 (8), 3221–3240. 10.1021/acs.jmedchem.6b01243
16
DixonS. J.LembergK. M.LamprechtM. R.SkoutaR.ZaitsevE. M.GleasonC. E.et al (2012). Ferroptosis: an Iron-dependent Form of Nonapoptotic Cell Death. Cell149 (5), 1060–1072. 10.1016/j.cell.2012.03.042
17
DixonS. J.StockwellB. R. (2014). The Role of Iron and Reactive Oxygen Species in Cell Death. Nat. Chem. Biol.10, 9–17. 10.1038/nchembio.1416
18
DizdarogluM.JarugaP. (2012). Mechanisms of Free Radical-Induced Damage to DNA. Free Radic. Res.46 (4), 382–419. 10.3109/10715762.2011.653969
19
DizdarogluM.RaoG.HalliwellB.GajewskiE. (1991). Damage to the DNA Bases in Mammalian Chromatin by Hydrogen Peroxide in the Presence of Ferric and Cupric Ions. Arch. Biochem. Biophys.285 (2), 317–324. 10.1016/0003-9861(91)90366-q
20
DollS.FreitasF. P.ShahR.AldrovandiM.da SilvaM. C.IngoldI.et al (2019). FSP1 Is a Glutathione-independent Ferroptosis Suppressor. Nature575 (7784), 693–698. 10.1038/s41586-019-1707-0
21
DongT.LiaoD.LiuX.LeiX. (2015). Using Small Molecules to Dissect Non-apoptotic Programmed Cell Death: Necroptosis, Ferroptosis, and Pyroptosis. Chembiochem16 (18), 2557–2561. 10.1002/cbic.201500422
22
DurazzoM.AdrianiA.FagooneeS.SaraccoG. M.PellicanoR. (2021). Helicobacter pylori and Respiratory Diseases: 2021 Update. Microorganisms9 (10), 2033. 10.3390/microorganisms9102033
23
FischbacherA.von SonntagC.SchmidtT. C. (2017). Hydroxyl Radical Yields in the Fenton Process under Various pH, Ligand Concentrations and Hydrogen peroxide/Fe(II) Ratios. Chemosphere182, 738–744. 10.1016/j.chemosphere.2017.05.039
24
Friedmann AngeliJ. P.KryskoD. V.ConradM. (2019). Ferroptosis at the Crossroads of Cancer-Acquired Drug Resistance and Immune Evasion. Nat. Rev. Cancer19 (7), 405–414. 10.1038/s41568-019-0149-1
25
GalluzziL.Bravo-San PedroJ. M.VitaleI.AaronsonS. A.AbramsJ. M.AdamD.et al (2015). Essential versus Accessory Aspects of Cell Death: Recommendations of the NCCD 2015. Cell Death Differ22 (1), 58–73. 10.1038/cdd.2014.137
26
GalluzziL.VitaleI.AaronsonS. A.AbramsJ. M.AdamD.AgostinisP.et al (2018). Molecular Mechanisms of Cell Death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cel Death Differ25 (3), 486–541. 10.1038/s41418-017-0012-4
27
GambardellaV.CastilloJ.TarazonaN.Gimeno-ValienteF.Martínez-CiarpagliniC.Cabeza-SeguraM.et al (2020). The Role of Tumor-Associated Macrophages in Gastric Cancer Development and Their Potential as a Therapeutic Target. Cancer Treat. Rev.86, 102015. 10.1016/j.ctrv.2020.102015
28
GaoM.YiJ.ZhuJ.MinikesA. M.MonianP.ThompsonC. B.et al (2019). Role of Mitochondria in Ferroptosis. Mol. Cel73 (2), 354–363. e3. 10.1016/j.molcel.2018.10.042
29
GaoZ.DengG.LiY.HuangH.SunX.ShiH.et al (2020). Actinidia Chinensis Planch Prevents Proliferation and Migration of Gastric Cancer Associated with Apoptosis, Ferroptosis Activation and Mesenchymal Phenotype Suppression. Biomed. Pharmacother.126, 110092. 10.1016/j.biopha.2020.110092
30
GinsbergG. G.Al-KawasF. H.FleischerD. E.ReillyH. F.BenjaminS. B. (1996). Gastric Polyps: Relationship of Size and Histology to Cancer Risk. Am. J. Gastroenterol.91 (4), 714–717.
31
GoddardA. F.JamesM. W.McIntyreA. S.ScottB. B.British Society of Gastroenterology (2011). Guidelines for the Management of Iron Deficiency Anaemia. Gut60 (10), 1309–1316. 10.1136/gut.2010.228874
32
GuanZ.ChenJ.LiX.DongN. (2020). Tanshinone IIA Induces Ferroptosis in Gastric Cancer Cells through P53-Mediated SLC7A11 Down-Regulation. Biosci. Rep.40 (8), BSR20201807. 10.1042/BSR20201807
33
HagymásiK.TulassayZ. (2014). Helicobacter Pyloriinfection: New Pathogenetic and Clinical Aspects. Wjg20 (21), 6386–6399. 10.3748/wjg.v20.i21.6386
34
HaoS.YuJ.HeW.HuangQ.ZhaoY.LiangB.et al (2017). Cysteine Dioxygenase 1 Mediates Erastin-Induced Ferroptosis in Human Gastric Cancer Cells. Neoplasia19 (12), 1022–1032. 10.1016/j.neo.2017.10.005
35
HassanniaB.VandenabeeleP.Vanden BergheT. (2019). Targeting Ferroptosis to Iron Out Cancer. Cancer Cell35 (6), 830–849. 10.1016/j.ccell.2019.04.002
36
HattaW.GotodaT.KoikeT.MasamuneA. (2020). History and Future Perspectives in Japanese Guidelines for Endoscopic Resection of Early Gastric Cancer. Dig. Endosc.32 (2), 180–190. 10.1111/den.13531
37
HenleE. S.LinnS. (1997). Formation, Prevention, and Repair of DNA Damage by Iron/hydrogen Peroxide. J. Biol. Chem.272 (31), 19095–19098. 10.1074/jbc.272.31.19095
38
HuangR.ChenH.LiangJ.LiY.YangJ.LuoC.et al (2021). Dual Role of Reactive Oxygen Species and Their Application in Cancer Therapy. J. Cancer12 (18), 5543–5561. 10.7150/jca.54699
39
HuangT.SongC.ZhengL.XiaL.LiY.ZhouY. (2019). The Roles of Extracellular Vesicles in Gastric Cancer Development, Microenvironment, Anti-cancer Drug Resistance, and Therapy. Mol. Cancer18 (1), 62. 10.1186/s12943-019-0967-5
40
InoueS.KawanishiS. (1987). Hydroxyl Radical Production and Human DNA Damage Induced by Ferric Nitrilotriacetate and Hydrogen Peroxide. Cancer Res.47 (24 Pt 1), 6522–6527.
41
JacobsonM. D.RaffM. C. (1995). Programmed Cell Death and Bcl-2 protection in Very Low Oxygen. Nature374 (6525), 814–816. 10.1038/374814a0
42
JanssenH. J. B.FransenL. F. C.PontenJ. E. H.NieuwenhuijzenG. A. P.LuyerM. D. P. (2020). Micronutrient Deficiencies Following Minimally Invasive Esophagectomy for Cancer. Nutrients12 (3), 778. 10.3390/nu12030778
43
JiangL.KonN.LiT.WangS.-J.SuT.HibshooshH.et al (2015). Ferroptosis as a P53-Mediated Activity during Tumour Suppression. Nature520 (7545), 57–62. 10.1038/nature14344
44
JiangX.YanQ.XieL.XuS.JiangK.HuangJ.et al (2021). Construction and Validation of a Ferroptosis-Related Prognostic Model for Gastric Cancer. J. Oncol.2021, 6635526. 10.1155/2021/6635526
45
JiangX.LiuF.LiuP.YanY.LanS.ZhuangK.et al (2021). Ferroptosis Patterns Correlate with Immune Microenvironment Characterization in Gastric Cancer. IjgmVol. 14, 6573–6586. 10.2147/ijgm.s331291
46
JiangY.XieJ.HuangW.ChenH.XiS.HanZ.et al (2019). Tumor Immune Microenvironment and Chemosensitivity Signature for Predicting Response to Chemotherapy in Gastric Cancer. Cancer Immunol. Res.7 (12), 2065–2073. 10.1158/2326-6066.CIR-19-0311
47
JiangY.WangH.WuJ.ChenC.YuanQ.HuangW.et al (2020). Noninvasive Imaging Evaluation of Tumor Immune Microenvironment to Predict Outcomes in Gastric Cancer. Ann. Oncol.31 (6), 760–768. 10.1016/j.annonc.2020.03.295
48
JinX.ZhuZ.ShiY. (2014). Metastasis Mechanism and Gene/protein Expression in Gastric Cancer with Distant Organs Metastasis. Bull. Cancer101 (1), E1–E12. 10.1684/bdc.2013.1882
49
JohnstonF. M.BeckmanM. (2019). Updates on Management of Gastric Cancer. Curr. Oncol. Rep.21 (8), 67. 10.1007/s11912-019-0820-4
50
KamadaT.MaruyamaY.MonobeY.HarumaK. (2021). Endoscopic Features and Clinical Importance of Autoimmune Gastritis. Dig. Endosc. (Online ahead of print). 10.1111/den.14175
51
KehrerJ. P. (2000). The Haber-Weiss Reaction and Mechanisms of Toxicity. Toxicology149 (1), 43–50. 10.1016/s0300-483x(00)00231-6
52
KerrJ. F. R.WyllieA. H.CurrieA. R. (1972). Apoptosis: A Basic Biological Phenomenon with Wideranging Implications in Tissue Kinetics. Br. J. Cancer26 (4), 239–257. 10.1038/bjc.1972.33
53
KlöditzK.FadeelB. (2019). Three Cell Deaths and a Funeral: Macrophage Clearance of Cells Undergoing Distinct Modes of Cell Death. Cel Death Discov.5, 65. 10.1038/s41420-019-0146-x
54
LambethJ. D.NeishA. S. (2014). Nox Enzymes and New Thinking on Reactive Oxygen: a Double-Edged Sword Revisited. Annu. Rev. Pathol. Mech. Dis.9, 119–145. 10.1146/annurev-pathol-012513-104651
55
LazărD. C.AvramM. F.RomoșanI.CornianuM.TăbanS.GoldișA. (2018). Prognostic Significance of Tumor Immune Microenvironment and Immunotherapy: Novel Insights and Future Perspectives in Gastric Cancer. World J. Gastroenterol.24 (32), 3583–3616. 10.3748/wjg.v24.i32.3583
56
LeeJ.-Y.NamM.SonH. Y.HyunK.JangS. Y.KimJ. W.et al (2020). Polyunsaturated Fatty Acid Biosynthesis Pathway Determines Ferroptosis Sensitivity in Gastric Cancer. Proc. Natl. Acad. Sci. U.S.A.117 (51), 32433–32442. 10.1073/pnas.2006828117
57
LiJ.XuL.RunZ.-C.FengW.LiuW.ZhangP.-J.et al (2018). Multiple Cytokine Profiling in Serum for Early Detection of Gastric Cancer. Wjg24 (21), 2269–2278. 10.3748/wjg.v24.i21.2269
58
LiW.FengG.GauthierJ. M.LokshinaI.HigashikuboR.EvansS.et al (2019). Ferroptotic Cell Death and TLR4/Trif Signaling Initiate Neutrophil Recruitment after Heart Transplantation. J. Clin. Invest. Feb 26129 (6), 2293–2304. 10.1172/jci126428
59
LiaoX.FanY.HouJ.ChenX.XuX.YangY.et al (2019). Identification of Chaetocin as a Potent Non-ROS-mediated Anticancer Drug Candidate for Gastric Cancer. J. Cancer10 (16), 3678–3690. 10.7150/jca.32803
60
LinkermannA.SkoutaR.HimmerkusN.MulayS. R.DewitzC.De ZenF.et al (2014). Synchronized Renal Tubular Cell Death Involves Ferroptosis. Proc. Natl. Acad. Sci. U.S.A.111 (47), 16836–16841. 10.1073/pnas.1415518111
61
LinkermannA.SkoutaR.HimmerkusN.MulayS. R.DewitzC.De ZenF.et al (2014). Synchronized Renal Tubular Cell Death Involves Ferroptosis. Proc. Natl. Acad. Sci. U.S.A.111 (47), 16836–16841. 10.1073/pnas.1415518111
62
LiuG.MaJ.-y.HuG.JinH. (2021). Identification and Validation of a Novel Ferroptosis-Related Gene Model for Predicting the Prognosis of Gastric Cancer Patients. PLoS One16 (7), e0254368. 10.1371/journal.pone.0254368
63
LiuS. J.YangY. B.ZhouJ. X.LinY. J.PanY. L.PanJ. H. (2021). A Novel Ferroptosis-Related Gene Risk Signature for Predicting Prognosis and Immunotherapy Response in Gastric Cancer. Dis. Markers2021, 2385406. 10.1155/2021/2385406
64
LordickF.ShitaraK.JanjigianY. Y. (2017). New Agents on the Horizon in Gastric Cancer. Ann. Oncol.28 (8), 1767–1775. 10.1093/annonc/mdx051
65
MachlowskaJ.MaciejewskiR.SitarzR. (2018). The Pattern of Signatures in Gastric Cancer Prognosis. Ijms19 (6), 1658. 10.3390/ijms19061658
66
MaoS.-H.ZhuC.-H.NieY.YuJ.WangL. (2021). Levobupivacaine Induces Ferroptosis by miR-489-3p/SLC7A11 Signaling in Gastric Cancer. Front. Pharmacol.12, 681338. 10.3389/fphar.2021.681338
67
MatsushitaM.FreigangS.SchneiderC.ConradM.BornkammG. W.KopfM. (2015). T Cell Lipid Peroxidation Induces Ferroptosis and Prevents Immunity to Infection. J. Exp. Med. Apr 6212 (4), 555–568. 10.1084/jem.20140857
68
MihmanliM.IlhanE.IdizU. O.AlemdarA.DemirU. (2016). Recent Developments and Innovations in Gastric Cancer. Wjg22 (17), 4307–4320. 10.3748/wjg.v22.i17.4307
69
MuckenthalerM. U.RivellaS.HentzeM. W.GalyB. (2017). A Red Carpet for Iron Metabolism. Cell168 (3), 344–361. 10.1016/j.cell.2016.12.034
70
NameeN. M.O'DriscollL. (2018). Extracellular Vesicles and Anti-cancer Drug Resistance. Biochim. Biophys. Acta (Bba) - Rev. Cancer1870 (2), 123–136. 10.1016/j.bbcan.2018.07.003
71
NiH.QinH.SunC.LiuY.RuanG.GuoQ.et al (2021). MiR-375 Reduces the Stemness of Gastric Cancer Cells through Triggering Ferroptosis. Stem Cel Res Ther12 (1), 325. 10.1186/s13287-021-02394-7
72
NiH.RuanG.SunC.YangX.MiaoZ.LiJ.et al (2021). Tanshinone IIA Inhibits Gastric Cancer Cell Stemness through Inducing Ferroptosis. Environ. Toxicol.37 (2), 192–200. 10.1002/tox.23388
73
NiuY.ZhangJ.TongY.LiJ.LiuB. (2019). RETRACTED: Physcion 8-O-β-Glucopyranoside Induced Ferroptosis via Regulating miR-103a-3p/GLS2 axis in Gastric Cancer. Life Sci.237, 116893. 10.1016/j.lfs.2019.116893
74
NomuraA.ChyouP. H.StemmermannG. N. (1992). Association of Serum Ferritin Levels with the Risk of Stomach Cancer. Cancer Epidemiol. Biomarkers Prev.1 (7), 547–550.
75
OyaY.HayakawaY.KoikeK. (2020). Tumor Microenvironment in Gastric Cancers. Cancer Sci.111 (8), 2696–2707. 10.1111/cas.14521
76
PalzerJ.EcksteinL.SlabuI.ReisenO.NeumannU. P.RoethA. A. (2021). Iron Oxide Nanoparticle-Based Hyperthermia as a Treatment Option in Various Gastrointestinal Malignancies. Nanomaterials11 (11), 3013. 10.3390/nano11113013
77
Pfeifhofer-ObermairC.TymoszukP.PetzerV.WeissG.NairzM. (2018). Iron in the Tumor Microenvironment-Connecting the Dots. Front. Oncol.8, 549. 10.3389/fonc.2018.00549
78
PráD.Rech FrankeS. I.Pêgas HenriquesJ. A.FenechM. (2009). A Possible Link between Iron Deficiency and Gastrointestinal Carcinogenesis. Nutr. Cancer61 (4), 415–426. 10.1080/01635580902803701
79
RojasA.ArayaP.GonzalezI.MoralesE. (2020). Gastric Tumor Microenvironment. Adv. Exp. Med. Biol.1226, 23–35. 10.1007/978-3-030-36214-0_2
80
SantoroR.EttorreG. M.SantoroE. (2014). Subtotal Gastrectomy for Gastric Cancer. Wjg20 (38), 13667–13680. 10.3748/wjg.v20.i38.13667
81
SchweichelJ. U.MerkerH. J. (1973). The Morphology of Various Types of Cell Death in Prenatal Tissues. Teratology7 (3), 253–266. 10.1002/tera.1420070306
82
ShaoL.ChenZ.SouttoM.ZhuS.LuH.Romero-GalloJ.et al (2019). Helicobacter pylori ‐induced miR‐135b‐5p Promotes Cisplatin Resistance in Gastric Cancer. FASEB j.33 (1), 264–274. 10.1096/fj.201701456rr
83
ShaoY.JiaH.LiS.HuangL.AikemuB.YangG.et al (2021). Comprehensive Analysis of Ferroptosis-Related Markers for the Clinical and Biological Value in Gastric Cancer. Oxid Med. Cel Longev2021, 7007933. 10.1155/2021/7007933
84
ShimadaK.HayanoM.PaganoN. C.StockwellB. R. (2016). Cell-Line Selectivity Improves the Predictive Power of Pharmacogenomic Analyses and Helps Identify NADPH as Biomarker for Ferroptosis Sensitivity. Cel Chem. Biol.23 (2), 225–235. 10.1016/j.chembiol.2015.11.016
85
ShinD.KimE. H.LeeJ.RohJ.-L. (2018). Nrf2 Inhibition Reverses Resistance to GPX4 Inhibitor-Induced Ferroptosis in Head and Neck Cancer. Free Radic. Biol. Med.129, 454–462. 10.1016/j.freeradbiomed.2018.10.426
86
SilvaM. M.RochaC. R. R.KinkerG. S.PelegriniA. L.MenckC. F. M. (2019). The Balance between NRF2/GSH Antioxidant Mediated Pathway and DNA Repair Modulates Cisplatin Resistance in Lung Cancer Cells. Sci. Rep.9 (1), 17639. 10.1038/s41598-019-54065-6
87
SmythE. C.NilssonM.GrabschH. I.van GriekenN. C.LordickF. (2020). Gastric Cancer. The Lancet396 (10251), 635–648. 10.1016/s0140-6736(20)31288-5
88
SoaresM. P.HamzaI. (2016). Macrophages and Iron Metabolism. Immunity44 (3), 492–504. 10.1016/j.immuni.2016.02.016
89
SongB.YuJ.WuT. S. (2015). Correlation between C-Erbb-2 with Gastric Mucosal Atypical Hyperplasia and Gastric Carcinoma. J. Biol. Regul. Homeost Agents29 (2), 471–477.
90
StockwellB. R.Friedmann AngeliJ. P.BayirH.BushA. I.ConradM.DixonS. J.et al (2017). Ferroptosis: A Regulated Cell Death Nexus Linking Metabolism, Redox Biology, and Disease. Cell171 (2), 273–285. 10.1016/j.cell.2017.09.021
91
StockwellB. R.JiangX.GuW. (2020). Emerging Mechanisms and Disease Relevance of Ferroptosis. Trends Cel Biol.30 (6), 478–490. 10.1016/j.tcb.2020.02.009
92
SunY.DengR.ZhangC. (2020). Erastin Induces Apoptotic and Ferroptotic Cell Death by Inducing ROS Accumulation by Causing Mitochondrial Dysfunction in Gastric Cancer Cell HGC-27. Mol. Med. Rep.22 (4), 2826–2832. 10.3892/mmr.2020.11376
93
TalvenmäkiH.LallukkaN.SurvoS.RomantschukM. (2019). Fenton's Reaction-Based Chemical Oxidation in Suboptimal Conditions Can lead to Mobilization of Oil Hydrocarbons but Also Contribute to the Total Removal of Volatile Compounds. Environ. Sci. Pollut. Res.26 (33), 34670–34684. 10.1007/s11356-019-06547-3
94
TanW. C.KrasnerN.O'TooleP.LombardM. (1997). Enhancement of Photodynamic Therapy in Gastric Cancer Cells by Removal of Iron. Gut41 (1), 14–18. 10.1136/gut.41.1.14
95
TanZ. (2019). Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med. Sci. Monit.25, 3537–3541. 10.12659/msm.916475
96
TangD.ChenX.KangR.KroemerG. (2021). Ferroptosis: Molecular Mechanisms and Health Implications. Cell Res31 (2), 107–125. 10.1038/s41422-020-00441-1
97
ToriiS.ShintokuR.KubotaC.YaegashiM.ToriiR.SasakiM.et al (2016). An Essential Role for Functional Lysosomes in Ferroptosis of Cancer Cells. Biochem. J.473 (6), 769–777. 10.1042/bj20150658
98
TortiS. V.TortiF. M. (2013). Iron and Cancer: More Ore to Be Mined. Nat. Rev. Cancer13, 342–355. 10.1038/nrc3495
99
UrsiniF.MaiorinoM.ValenteM.FerriL.GregolinC. (1982). Purification from Pig Liver of a Protein Which Protects Liposomes and Biomembranes from Peroxidative Degradation and Exhibits Glutathione Peroxidase Activity on Phosphatidylcholine Hydroperoxides. Biochim. Biophys. Acta (Bba) - Lipids Lipid Metab.710 (2), 197–211. 10.1016/0005-2760(82)90150-3
100
VinchiF.PortoG.SimmelbauerA.AltamuraS.PassosS. T.GarbowskiM.et al (2019). Atherosclerosis Is Aggravated by Iron Overload and Ameliorated by Dietary and Pharmacological Iron Restriction. Eur. Heart J.00, 1–16. 10.1093/eurheartj/ehz112
101
WangF.ChenC.ChenW. P.LiZ. L.ChengH. (2021). Development and Validation of a Novel Ferroptosis-Related Gene Signature for Predicting Prognosis and the Immune Microenvironment in Gastric Cancer. Biomed. Res. Int.2021, 6014202. 10.1155/2021/6014202
102
WangJ.WangT.ZhangY.LiuJ.SongJ.HanY.et al (2021). CPEB1 Enhances Erastin‐induced Ferroptosis in Gastric Cancer Cells by Suppressing Twist1 Expression. IUBMB Life73 (9), 1180–1190. 10.1002/iub.2525
103
WangS.-F.ChenM.-S.ChouY.-C.UengY.-F.YinP.-H.YehT.-S.et al (2016). Mitochondrial Dysfunction Enhances Cisplatin Resistance in Human Gastric Cancer Cells via the ROS-Activated GCN2-eIF2α-ATF4-xCT Pathway. Oncotarget7 (45), 74132–74151. 10.18632/oncotarget.12356
104
WangS.ChenZ.ZhuS.LuH.PengD.SouttoM.et al (2020). PRDX2 Protects against Oxidative Stress Induced by H. pylori and Promotes Resistance to Cisplatin in Gastric Cancer. Redox Biol.28, 101319. 10.1016/j.redox.2019.101319
105
WeiL.SunJ.ZhangN.ZhengY.WangX.LvL.et al (2020). Noncoding RNAs in Gastric Cancer: Implications for Drug Resistance. Mol. Cancer19 (1), 62. 10.1186/s12943-020-01185-7
106
XiangR.SongW.RenJ.WuJ.FuJ.FuT. (2021). Identification of Stem Cell-Related Subtypes and Risk Scoring for Gastric Cancer Based on Stem Genomic Profiling. Stem Cel Res Ther12 (1), 563. 10.1186/s13287-021-02633-x
107
XiaoS.LiuX.YuanL.ChenX.WangF. (2021). Expression of Ferroptosis-Related Genes Shapes Tumor Microenvironment and Pharmacological Profile in Gastric Cancer. Front. Cel Dev. Biol.9, 694003. 10.3389/fcell.2021.694003
108
XuZ.FengJ.LiY.GuanD.ChenH.ZhaiX.et al (2020). The Vicious Cycle between Ferritinophagy and ROS Production Triggered EMT Inhibition of Gastric Cancer Cells Was through p53/AKT/mTor Pathway. Chemico-Biological Interactions328, 109196. 10.1016/j.cbi.2020.109196
109
YamaguchiS.HamanoT.OkaT.DoiY.KajimotoS.ShimadaK.et al (2021). Mean Corpuscular Hemoglobin Concentration: an Anemia Parameter Predicting Cardiovascular Disease in Incident Dialysis Patients. J. Nephrol.35 (2), 535–544. 10.1007/s40620-021-01107-w
110
YangW.MaJ.ZhouW.CaoB.ZhouX.YangZ.et al (2017). Molecular Mechanisms and Theranostic Potential of miRNAs in Drug Resistance of Gastric Cancer. Expert Opin. Ther. Targets21 (11), 1063–1075. 10.1080/14728222.2017.1389900
111
YangW. S.KimK. J.GaschlerM. M.PatelM.ShchepinovM. S.StockwellB. R. (2016). Peroxidation of Polyunsaturated Fatty Acids by Lipoxygenases Drives Ferroptosis. Proc. Natl. Acad. Sci. U S A.113 (34), E4966–E4975. 10.1073/pnas.1603244113
112
YangW. S.SriRamaratnamR.WelschM. E.ShimadaK.SkoutaR.ViswanathanV. S.et al (2014). Regulation of Ferroptotic Cancer Cell Death by GPX4. Cell156 (1-2), 317–331. 10.1016/j.cell.2013.12.010
113
YangW. S.StockwellB. R. (2008). Synthetic Lethal Screening Identifies Compounds Activating Iron-dependent, Nonapoptotic Cell Death in Oncogenic-RAS-Harboring Cancer Cells. Chem. Biol.15 (3), 234–245. 10.1016/j.chembiol.2008.02.010
114
ZavrosY. (2017). Initiation and Maintenance of Gastric Cancer: A Focus on CD44 Variant Isoforms and Cancer Stem Cells. Cell Mol. Gastroenterol. Hepatol.4 (1), 55–63. 10.1016/j.jcmgh.2017.03.003
115
ZhaiJ.ShenJ.XieG.WuJ.HeM.GaoL.et al (2019). Cancer-associated Fibroblasts-Derived IL-8 Mediates Resistance to Cisplatin in Human Gastric Cancer. Cancer Lett.454, 37–43. 10.1016/j.canlet.2019.04.002
116
ZhangH.DengT.LiuR.NingT.YangH.LiuD.et al (2020). CAF Secreted miR-522 Suppresses Ferroptosis and Promotes Acquired Chemo-Resistance in Gastric Cancer. Mol. Cancer19 (1), 43. 10.1186/s12943-020-01168-8
117
ZhangH.WangM.HeY.DengT.LiuR.WangW.et al (2021). Chemotoxicity-induced Exosomal lncFERO Regulates Ferroptosis and Stemness in Gastric Cancer Stem Cells. Cell Death Dis12 (12), 1116. 10.1038/s41419-021-04406-z
118
ZhengJ.ConradM. (2020). The Metabolic Underpinnings of Ferroptosis. Cel Metab.32 (6), 920–937. 10.1016/j.cmet.2020.10.011
119
ZhouL.ZhaoB.ZhangL.WangS.DongD.LvH.et al (2018). Alterations in Cellular Iron Metabolism Provide More Therapeutic Opportunities for Cancer. Ijms19 (5), 1545. 10.3390/ijms19051545
120
ZhuQ.GuoY.ChenS.FuD.LiY.LiZ.et al (2020). Irinotecan Induces Autophagy-dependent Apoptosis and Positively Regulates ROS-Related JNK- and P38-MAPK Pathways in Gastric Cancer Cells. OttVol. 13, 2807–2817. 10.2147/ott.s240803
Summary
Keywords
ferroptosis, iron, gastric cancer, ROS, microenvironment, drug resistance
Citation
Gu R, Xia Y, Li P, Zou D, Lu K, Ren L, Zhang H and Sun Z (2022) Ferroptosis and its Role in Gastric Cancer. Front. Cell Dev. Biol. 10:860344. doi: 10.3389/fcell.2022.860344
Received
22 January 2022
Accepted
28 March 2022
Published
30 June 2022
Volume
10 - 2022
Edited by
Haiyang Zhang, Tianjin Medical University, China
Reviewed by
Yihuang Gu, Nanjing University, China
Zhengyu Li, Shanghai University of Traditional Chinese Medicine, China
Updates
Copyright
© 2022 Gu, Xia, Li, Zou, Lu, Ren, Zhang and Sun.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Hongru Zhang, zhr5001@vip.163.com; Zhiguang Sun, zhiguangsun@njucm.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Cell Death and Survival, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.